Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH)

INTRODUCTION: Vasopressin is an alternative vasopressor in the management of septic shock. It spares catecholamine use but whether it improves outcome remains uncertain. Current evidence suggests that it may be most effective if used early and possibly in conjunction with corticosteroids. This trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Anthony C, Mason, Alexina J, Perkins, Gavin D, Ashby, Deborah, Brett, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091463/
https://www.ncbi.nlm.nih.gov/pubmed/24993769
http://dx.doi.org/10.1136/bmjopen-2014-005866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091463/
https://www.ncbi.nlm.nih.gov/pubmed/24993769
http://dx.doi.org/10.1136/bmjopen-2014-005866

Ejemplares similares